| Characteristics . | Dapoxetine 30 mg only (N = 1,052) n (%) . | Dapoxetine 30→60 mg (N = 192) n (%) . | Total (N = 1,244) n (%) . |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 32.43 (7.08) | 33.58 (7.24) | 32.61 (7.12) |
| Weight (kg) | |||
| Mean (SD) | 71.37 (10.41) | 73.77 (11.44) | 71.74 (10.60) |
| Height (cm) | |||
| Mean (SD) | 172.57 (5.13) | 173.34 (4.56) | 172.69 (5.06) |
| BMI (kg/m2) | |||
| Mean (SD) | 23.95 (3.21) | 24.51 (3.38) | 24.04 (3.25) |
| IIEF-5 score | |||
| Mean (SD) | 23.18 (1.42) | 22.82 (1.40) | 23.12 (1.42) |
| Characteristics . | Dapoxetine 30 mg only (N = 1,052) n (%) . | Dapoxetine 30→60 mg (N = 192) n (%) . | Total (N = 1,244) n (%) . |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 32.43 (7.08) | 33.58 (7.24) | 32.61 (7.12) |
| Weight (kg) | |||
| Mean (SD) | 71.37 (10.41) | 73.77 (11.44) | 71.74 (10.60) |
| Height (cm) | |||
| Mean (SD) | 172.57 (5.13) | 173.34 (4.56) | 172.69 (5.06) |
| BMI (kg/m2) | |||
| Mean (SD) | 23.95 (3.21) | 24.51 (3.38) | 24.04 (3.25) |
| IIEF-5 score | |||
| Mean (SD) | 23.18 (1.42) | 22.82 (1.40) | 23.12 (1.42) |
IIEF = International Index of Erectile Function; BMI = body mass index, N/n = number of patients, SD = standard deviation.
Age was derived as (date of informed consent–date of birth)/365.25.
The distribution of demographic and baseline characteristics among 2 treatment groups was analyzed using chi-square or Fisher's exact test for categorical variables and t-test for continuous variables.
Baseline was defined as the value obtained at the consultation visit.
| Characteristics . | Dapoxetine 30 mg only (N = 1,052) n (%) . | Dapoxetine 30→60 mg (N = 192) n (%) . | Total (N = 1,244) n (%) . |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 32.43 (7.08) | 33.58 (7.24) | 32.61 (7.12) |
| Weight (kg) | |||
| Mean (SD) | 71.37 (10.41) | 73.77 (11.44) | 71.74 (10.60) |
| Height (cm) | |||
| Mean (SD) | 172.57 (5.13) | 173.34 (4.56) | 172.69 (5.06) |
| BMI (kg/m2) | |||
| Mean (SD) | 23.95 (3.21) | 24.51 (3.38) | 24.04 (3.25) |
| IIEF-5 score | |||
| Mean (SD) | 23.18 (1.42) | 22.82 (1.40) | 23.12 (1.42) |
| Characteristics . | Dapoxetine 30 mg only (N = 1,052) n (%) . | Dapoxetine 30→60 mg (N = 192) n (%) . | Total (N = 1,244) n (%) . |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 32.43 (7.08) | 33.58 (7.24) | 32.61 (7.12) |
| Weight (kg) | |||
| Mean (SD) | 71.37 (10.41) | 73.77 (11.44) | 71.74 (10.60) |
| Height (cm) | |||
| Mean (SD) | 172.57 (5.13) | 173.34 (4.56) | 172.69 (5.06) |
| BMI (kg/m2) | |||
| Mean (SD) | 23.95 (3.21) | 24.51 (3.38) | 24.04 (3.25) |
| IIEF-5 score | |||
| Mean (SD) | 23.18 (1.42) | 22.82 (1.40) | 23.12 (1.42) |
IIEF = International Index of Erectile Function; BMI = body mass index, N/n = number of patients, SD = standard deviation.
Age was derived as (date of informed consent–date of birth)/365.25.
The distribution of demographic and baseline characteristics among 2 treatment groups was analyzed using chi-square or Fisher's exact test for categorical variables and t-test for continuous variables.
Baseline was defined as the value obtained at the consultation visit.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
